John G. Bartlett

Q: What Schools Are Affiliated With John G. Bartlett

John G. Bartlett is affiliated with the following schools: Yale University, Loyola University Chicago, Johns Hopkins University

John G. Bartlett's AcademicInfluence.com Rankings

John G. Bartlett

Philosophy

#1704

World Rank

#3042

Historical Rank

#663

USA Rank

Logic

#283

World Rank

#579

Historical Rank

#119

USA Rank

philosophy Degrees

Download Badge

Philosophy

Why Is John G. Bartlett Influential?

(Suggest an Edit or Addition)

According to Wikipedia, John Gill Bartlett was an American physician and medical researcher, specializing in infectious diseases. He is known as a pioneer in HIV/AIDS research and for his work on vancomycin as a treatment for Clostridioides difficile infection.

(See a Problem?)

John G. Bartlett's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults (2007) (5734)
Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. (2009) (3704)
Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents, January 28, 2000 (1998) (3678)
Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults (2000) (2147)
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. (2016) (2131)
The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. (2008) (1496)
Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. (1978) (1323)
Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. (2010) (1201)
Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. (2006) (1085)
Update of Practice Guidelines for the Management of Community-Acquired Pneumonia in Immunocompetent Adults (2003) (1016)
Clinical practice. Antibiotic-associated diarrhea. (2002) (889)
Community-Acquired Pneumonia in Adults: Guidelines for Management (1998) (854)
Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. (2005) (753)
Narrative Review: The New Epidemic of Clostridium difficileAssociated Enteric Disease (2006) (633)
Guidelines for Improving Entry Into and Retention in Care and Antiretroviral Adherence for Persons With HIV: Evidence-Based Recommendations From an International Association of Physicians in AIDS Care Panel (2012) (609)
Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. (2004) (604)
Clinical recognition and diagnosis of Clostridium difficile infection. (2008) (561)
The future of antibiotics and resistance. (2013) (557)
Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV-1 Transmission in the United States (2004) (550)
Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis. (1978) (509)
Guidelines for Using Antiretroviral Agents among HIV-Infected Adults and Adolescents: The Panel on Clinical Practices for Treatment of HIV* (2002) (500)
Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. (2003) (500)
Guidelines for evaluation of new fever in critically ill adult patients: 2008 update from the American College of Critical Care Medicine and the Infectious Diseases Society of America (2008) (493)
Guidelines for preventing opportunistic infections among HIV-infected persons - 2002 (2002) (474)
Antibiotic associated diarrhea. (2002) (456)
Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. (2010) (440)
Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters. (1977) (439)
Product information. (1999) (401)
A fiberoptic bronchoscopy technique to obtain uncontaminated lower airway secretions for bacterial culture. (2015) (394)
Executive Summary: Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. (2016) (385)
Antimicrobial prophylaxis for surgery: An advisory statement from the national surgical infection prevention project (2004) (373)
Cytomegalovirus retinitis and acquired immunodeficiency syndrome. (1989) (371)
Microbial synergy in experimental intra-abdominal abscess (1976) (364)
Seven ways to preserve the miracle of antibiotics. (2013) (357)
Preoperative Oral Antibiotics Reduce Septic Complications of Colon Operations: Results of Prospective, Randomized, Double‐blind Clinical Study (1977) (354)
Anaerobic infections. 1. (1974) (351)
Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis (1991) (351)
Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study (2004) (349)
The capsular polysaccharide of Bacteroides fragilis as a virulence factor: comparison of the pathogenic potential of encapsulated and unencapsulated strains. (1977) (327)
Medical Management of HIV Infection (1996) (326)
Clostridium difficile: history of its role as an enteric pathogen and the current state of knowledge about the organism. (1994) (318)
Anaerobic infections of the lung and pleural space. (2015) (315)
Combination antiretroviral therapy and the risk of myocardial infarction (2004) (314)
The bacteriology of aspiration pneumonia. (1974) (310)
Experimental Intra-Abdominal Abscesses in Rats: Development of an Experimental Model (1974) (306)
Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients (2004) (305)
Quantitative bacteriology of the vaginal flora. (1977) (304)
Comparison of two toxins produced by Clostridium difficile (1981) (304)
Virology: SARS virus infection of cats and ferrets (2004) (278)
Infectious gastroenteritis in bone-marrow-transplant recipients. (1982) (278)
Ocular manifestations of acquired immune deficiency syndrome. (1989) (267)
Prevalence of enteric pathogens in homosexual men with and without acquired immunodeficiency syndrome. (1988) (263)
International prospective study of klebsiella pneumoniae bacteremia: Implications of extended-spectrum β-lactamase production in nosocomial infections (2004) (248)
GUIDELINE FOR HAND HYGIENE IN HEALTH-CARE SETTINGS (2002) (244)
Bacteriology of hospital-acquired pneumonia. (1986) (243)
Principles of appropriate antibiotic use for acute pharyngitis in adults: background. (2001) (242)
Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations (1981) (238)
Prognostic indicators for AIDS and infectious disease death in HIV-infected injection drug users: plasma viral load and CD4+ cell count. (1998) (237)
Methicillin-resistant Staphylococcus aureus infections in correctional facilities---Georgia, California, and Texas, 2001-2003. (2003) (234)
Antimicrobial therapy of experimental intraabdominal sepsis. (1975) (230)
Major controversies in the DHHS guidelines for use of antiretroviral agents in HIV-infected adults. Department of Health and Human Services. (1998) (229)
Biology of Clostridium difficile: implications for epidemiology and diagnosis. (2011) (229)
Cytotoxicity assay in antibiotic-associated colitis. (1979) (228)
The triple threat of aspiration pneumonia. (1975) (226)
Historical perspectives on studies of Clostridium difficile and C. difficile infection. (2008) (223)
Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial. (2020) (215)
Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV. (2002) (214)
Diagnostic tests for agents of community-acquired pneumonia. (2011) (211)
Timing of antibiotic administration and outcomes for medicare patients hospitalized with community-acquired pneumonia (2004) (210)
Serum antibody response to toxins A and B of Clostridium difficile. (1983) (207)
Clostridium difficile: clinical considerations. (1990) (207)
Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations. (1981) (207)
Experimental Intra-Abdominal Abscesses in Rats: Quantitative Bacteriology of Infected Animals (1974) (206)
AIDS enteropathy: occult enteric infections and duodenal mucosal alterations in chronic diarrhea. (1991) (206)
Antibiotic-associated pseudomembranous colitis. (1979) (195)
Bacteriology of empyema. (1974) (194)
Septic and Technical Complications of Central Venous Catheterization: A Prospective Study of 200 Consecutive Patients (1985) (189)
Clostridium difficile Colitis: An Efficient Clinical Approach to Diagnosis (1995) (187)
Antibiotic-associated diarrhea. (1980) (186)
Anaerobic bacterial infections of the lung and pleural space. (1993) (182)
Erratum: Bad bugs need drugs: An update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America (Clinical Infectious Diseases (March 1, 2006) 42 (657-668)) (2006) (180)
Death due to bioterrorism-related inhalational anthrax: report of 2 patients. (2001) (179)
Should fiberoptic bronchoscopy aspirates be cultured? (2015) (166)
Clinical and laboratory observations in Clostridium difficile colitis. (1980) (165)
Aerobic and Anaerobic Bacteria in Diabetic Foot Ulcers (1976) (163)
Clindamycin-induced enterocolitis in hamsters as a model of pseudomembranous colitis in patients (1978) (163)
The new Clostridium difficile--what does it mean? (2005) (162)
Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children (2004) (158)
Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance (2004) (158)
Bacteriology of expectorated sputum with quantitative culture and wash technique compared to transtracheal aspirates. (2015) (158)
Rapid diagnosis of anaerobic infections by direct gas-liquid chromatography of clinical speciments. (1976) (154)
Practice parameters for evaluating new fever in critically ill adult patients (1998) (152)
HUMAN METAPNEUMOVIRUS AS A CAUSE OF COMMUNITY-ACQUIRED RESPIRATORY ILLNESS (2002) (152)
Anaerobic pleuropulmonary infections. (1972) (151)
A review. Lessons from an animal model of intra-abdominal sepsis. (1978) (151)
Community-acquired pneumonia. (2013) (151)
AIDS and ophthalmology: a period of transition. (1997) (143)
Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient (2004) (139)
Transmission of west nile virus through blood transfusion in the United States in 2002 (2004) (137)
Pseudomembranous colitis: a surgical disease? (1994) (135)
Male circumcision and risk of HIV-1 and other sexually transmitted infections in India (2004) (134)
Colitis induced by Clostridium difficile. (1979) (133)
Community-acquired pneumonia in adults: guidelines for management. The Infectious Diseases Society of America. (1998) (133)
Costs of HIV medical care in the era of highly active antiretroviral therapy. (1999) (131)
Management of anaerobic infections. (1975) (128)
Opt-out testing for human immunodeficiency virus in the United States: progress and challenges. (2008) (128)
Treatment of antibiotic-associated pseudomembranous colitis. (1984) (126)
Anaerobic infections (second of three parts). (1974) (126)
Impact of an antimicrobial stewardship intervention on shortening the duration of therapy for community-acquired pneumonia. (2012) (125)
Management of anthrax. (2002) (125)
Practice guidelines for evaluating new fever in critically ill adult patients. Task Force of the Society of Critical Care Medicine and the Infectious Diseases Society of America. (1998) (124)
Activities of Nigerian chewing stick extracts against Bacteroides gingivalis and Bacteroides melaninogenicus (1988) (123)
Veterans Administration Cooperative Study on Bowel Preparation for Elective Colorectal Operations: Impact of Oral Antibiotic Regimen on Colonic Flora, Wound Irrigation Cultures and Bacteriology of Septic Complications (1978) (120)
USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: disease-specific recommendations. USPHS/IDSA Prevention of Opportunistic Infections Working Group. (1995) (120)
Enzyme immunoassays for detection of Clostridium difficile toxins A and B in fecal specimens. (1984) (119)
Community‐Acquired Pneumonia: Impact of Immune Status (1996) (119)
Concepts of fever: recent advances and lingering dogma. (1997) (116)
Binding of Clostridium difficile cytotoxin and vancomycin by anion-exchange resins. (1980) (116)
Rising Economic Impact of Clostridium difficile-Associated Disease in Adult Hospitalized Patient Population (2008) (114)
Clindamycin-associated colitis in hamsters: protection with vancomycin. (1977) (112)
Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia (2004) (110)
Diagnostic accuracy of transtracheal aspiration bacteriologic studies. (2015) (110)
Anaerobic bacterial infections of the lung. (1987) (110)
Glanders in a military research microbiologist. (2001) (107)
Evolving Understanding of the Causes of Pneumonia in Adults, With Special Attention to the Role of Pneumococcus (2017) (107)
It is time to implement routine, not risk-based, HIV testing. (2005) (106)
Antibiotic-associated pseudomembranous colitis. (1981) (105)
Therapeutic efficacy of 29 antimicrobial regimens in experimental intraabdominal sepsis. (1981) (104)
Symptomatic relapse after oral vancomycin therapy of antibiotic-associated pseudomembranous colitis (1980) (103)
Treatment of anaerobic infections with lincomycin and clindamycin. (1972) (102)
Anaerobic infections of the head and neck. (1976) (101)
Bacteriology and treatment of primary lung abscess. (2015) (101)
Bacteriological studies of experimental ulcerative colitis. (1979) (101)
In vitro susceptibility of Clostridium difficile isolates from patients with antibiotic-associated diarrhea or colitis (1980) (100)
Public health guidance for community-level preparedness and response to severe acute respiratory syndrome (SARS) (2004) (100)
Preoperative prophylactic cephalothin fails to control septic complications of colorectal operations: results of controlled clinical trial. A Veterans Administration cooperative study. (1979) (100)
Efficacy of oral and systemic antibiotic prophylaxis in colorectal operations. (1983) (99)
Quantitative PCR Assay Using Sputum Samples for Rapid Diagnosis of Pneumococcal Pneumonia in Adult Emergency Department Patients (2005) (99)
Treatment of aspiration pneumonia and primary lung abscess. Penicillin G vs clindamycin. (1975) (99)
White paper: recommendations on the conduct of superiority and organism-specific clinical trials of antibacterial agents for the treatment of infections caused by drug-resistant bacterial pathogens. (2012) (98)
Antibiotic-associated colitis. (1984) (98)
Clostridium difficile: progress and challenges (2010) (97)
Anti-infective research and development--problems, challenges, and solutions. (2007) (96)
Treatment for adult HIV infection: 2004 recommendations of the international AIDS society-USA panel (2004) (95)
The case for vancomycin as the preferred drug for treatment of Clostridium difficile infection. (2008) (95)
A call to arms: the imperative for antimicrobial stewardship. (2011) (94)
Cultures for Clostridium difficile in stools containing a cytotoxin neutralized by Clostridium sordellii antitoxin (1979) (93)
PROTECTIVE. EFFECT OF METRONIDAZOLE IN EXPERIMENTALULCERATIVE COLITIS (1978) (92)
Symptomatic relapse after oral vancomycin therapy of antibiotic-associated pseudomembranous colitis. (1980) (91)
Percutaneous transtracheal aspiration in the diagnosis of anaerobic pulmonary infection. (1973) (91)
Principles of appropriate antibiotic use for acute rhinosinusitis in adults: background. (2001) (90)
Racial and Ethnic Differences in Outcome in Zidovudine-Treated Patients With Advanced HIV Disease (1991) (90)
Clostridium difficile in gnotobiotic mice (1980) (89)
Experimental animal models for anaerobic infections. (1979) (89)
Antibiotic-induced lethal enterocolitis in hamsters: studies with eleven agents and evidence to support the pathogenic role of toxin-producing Clostridia. (1978) (89)
The clinical spectrum of Staphylococcus aureus pulmonary infection. (1990) (87)
Comparison of once-daily atazanavir with efavirenz, each in combination with fixed-dose zidovudine and lamivudine, as initial therapy for patients infected with HIV (2004) (87)
Novel approaches are needed to develop tomorrow's antibacterial therapies. (2015) (85)
Efficacy of combined jejunal and colonic fecal microbiota transplantation for recurrent Clostridium difficile Infection. (2014) (85)
Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infection (2004) (84)
Pseudomembranous enterocolitis (antibiotic-related colitis). (1977) (83)
Implications for macrolide treatment in community-acquired pneumonia. Hopkins CAP Team. (1998) (83)
Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. Rhamnosus GG (2004) (81)
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial (2004) (81)
Effect of environmental stress on Clostridium difficile toxin levels during continuous cultivation (1979) (81)
Studies of ocular complications of AIDS Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 1. Rationale, design, and methods. AIDS Clinical Trials Group (ACTG). (1992) (81)
Anaerobic Infections. (1974) (79)
Cervical and vaginal bacterial flora: ecologic niches in the female lower genital tract. (1978) (79)
The role of the intestinal microflora in experimental colitis. (1977) (79)
Improvement in the health of HIV-infected persons in care: reducing disparities. (2012) (78)
Antibacterial properties of lidocaine. (1979) (78)
Association between Use of HMG CoA Reductase Inhibitors and Mortality in HIV-Infected Patients (2011) (78)
Association of gastric hypoacidity with opportunistic enteric infections in patients with AIDS. (1992) (77)
Anaerobic microflora of the vagina in children. (1978) (75)
Mupirocin prophylaxis against nosocomial staphylococcus aureus infections in nonsurgical patients: A randomized study (2004) (74)
Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines (2004) (73)
Antimicrobial stewardship: importance for patient and public health. (2014) (73)
The role of anaerobic bacteria in lung abscess. (2005) (72)
Antimicrobial resistance trends and outbreak frequency in united states hospitals (2004) (71)
Adherence of Bacteroides fragilis in vivo (1978) (70)
Antimicrobial agents for complicated skin and skin-structure infections: justification of noninferiority margins in the absence of placebo-controlled trials. (2009) (70)
Antibiotic levels in infected and sterile subcutaneous abscesses in mice. (1981) (69)
Planning for Avian Influenza (2006) (69)
Morbidity and toxic effects associated with ganciclovir or foscarnet therapy in a randomized cytomegalovirus retinitis trial. Studies of ocular complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group. (1995) (68)
Principles of appropriate antibiotic use for treatment of uncomplicated acute bronchitis: Background☆1☆2☆3☆4☆5☆6☆7☆8 (2001) (68)
Detection of Clostridium botulinum type A toxin by enzyme-linked immunosorbent assay with antibodies produced in immunologically tolerant animals (1984) (68)
Myoelectric effects of Clostridium difficile: motility-altering factors distinct from its cytotoxin and enterotoxin in rabbits. (1982) (67)
Amphotericin B: Time for a new “gold standard” (2004) (67)
Avian influenza A (H5N1) in 10 patients in Vietnam (2004) (65)
Anaerobes survive in clinical specimens despite delayed processing (1976) (64)
Treatment of Relapsing Clostridium difficile Diarrhea with Lactobacillus GG (1996) (64)
Community-acquired pneumonia. (2009) (64)
Norfloxacin for prevention of bacterial infections in granulocytopenic patients. (1987) (64)
Antibiotic-associated colitis. (1979) (63)
Survival of human immunodeficiency virus-infected liver transplant recipients (2004) (63)
Postantibiotic Colonization with Clostridium difficile in Nursing Home Patients (1990) (63)
The bacteriology of perimandibular space infections. (1979) (63)
Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults: background. (2001) (63)
A fresh look at the definition of susceptibility of Streptococcus pneumoniae to beta-lactam antibiotics. (2001) (62)
Antimicrobial agents implicated in Clostridium difficile toxin-associated diarrhea of colitis. (1981) (62)
Protective efficacy of immunization with capsular antigen against experimental infection with Bacteroides fragilis. (1979) (62)
Amikacin therapy for severe gram-negative sepsis. Emphasis on infections with gentamicin-resistant organisms. (1975) (61)
Bacitracin treatment of antibiotic-associated colitis and diarrhea caused by Clostridium difficile toxin. (1980) (61)
Methods for quantitative vaginal flora studies. (1977) (61)
Clinical trial of cefamandole, cefazolin, and cefuroxime for antibiotic prophylaxis in cardiac operations. (1993) (60)
Human immunodeficiency virus 1 infection, cocaine, and coronary calcification. (2005) (60)
1999 USPHS/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons Infected with Human Immunodeficiency Virus (1999) (59)
Early mobilization of patients hospitalized with community-acquired pneumonia (2004) (58)
Clostridium difficile: an under-recognized cause of reactive arthritis? (2008) (58)
Anaerobic bacterial infection of the lung. (2012) (58)
Aerobic and anaerobic bacteria in diabetic foot ulcers. (1977) (58)
Evaluation of new anti-infective drugs for the treatment of intraabdominal infections. Infectious Diseases Society of America and the Food and Drug Administration. (1992) (58)
Improved enzyme immunoassays for the detection of antigens in fecal specimens. Investigation and correction of interfering factors. (1984) (57)
Quantitative tracheal bacteriologic and cytologic studies in patients with long-term tracheostomies. (1978) (57)
Protease Inhibitors for HIV Infection (1996) (56)
Mental Health in the Workplace: A Call to Action Proceedings From the Mental Health in the Workplace—Public Health Summit (2017) (56)
Bacterial flora of the vagina: quantitative study. (1984) (56)
Enzyme-linked immunosorbent assay for detection of Clostridium botulinum type A and type B toxins in stool samples of infants with botulism (1984) (56)
Activity of metronidazole against Escherichia coli in experimental intra-abdominal sepsis. (1979) (56)
ANTIBIOTIC-ASSOCIATED PSEUDOMEMBRANOUS COLITIS IN CHILDREN (1981) (55)
Partial purification and characterization of a cytotoxin from Clostridium difficile. (1979) (55)
Once-daily versus twice-daily lopinavir/ritonavir in antiretroviral-naive HIV-positive patients: A 48-week randomized clinical trial (2004) (55)
Protective effect of metronidazole in experimental ulcerative colitis. (1978) (55)
Investigation of rabies infections in organ donor and transplant recipients--Alabama, Arkansas, Oklahoma, and Texas, 2004. (2004) (55)
Management of Clostridium difficile infection and other antibiotic-associated diarrhoeas. (1996) (54)
Dramatic decline in the HIV-1 RNA level over calendar time in a large urban HIV practice. (2011) (54)
How important are anaerobic bacteria in aspiration pneumonia: when should they be treated and what is optimal therapy. (2013) (54)
Anaerobic Infections: Old Myths and New Realities (1974) (54)
Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 5. Clinical features of cytomegalovirus retinitis at diagnosis. Studies of ocular complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group. (1997) (54)
Surface antigens as virulence factors in infection with Bacteroides fragilis. (1979) (53)
Update: influenza-associated deaths reported among children aged <18 years--United States, 2003-04 influenza season. (2004) (52)
Diagnosis of bacterial infections of the lung. (1987) (52)
Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand (2004) (52)
Decline in the AIDS and Death Rates in the EuroSIDA study: An observational study (2004) (52)
Colitis associated with metronidazole therapy. (1980) (51)
New drugs for Clostridium difficile infection. (2006) (51)
Highly active antiretroviral therapy and sexual risk behavior: A metaanalytic review (2004) (51)
Clostridium difficile in a HIV-infected cohort: incidence, risk factors, and clinical outcomes (2013) (50)
Effect of antibacterial home cleaning and handwashing products on infectious disease symptoms: a randomized, double-blind trial (2004) (50)
Acid dissociation increases the sensitivity of p24 antigen detection for the evaluation of antiviral therapy and disease progression in asymptomatic human immunodeficiency virus-infected persons. (1992) (50)
Impact of Toxigenic Clostridium difficile Colonization on the Risk of Subsequent C. difficile Infection in Intensive Care Unit Patients (2015) (49)
Decline in microbial studies for patients with pulmonary infections. (2004) (49)
Weight loss and wasting in patients infected with human immunodeficiency virus (2004) (49)
A quantitative model for subcutaneous abscess formation in mice. (1980) (48)
Anaerobic bacterial pneumonitis. (1979) (48)
Clostridium difficile toxin. (1981) (48)
Dual HIV-1 infection associated with rapid disease progression (2004) (48)
Comparative efficacy of 10 antimicrobial agents in experimental infections with Bacteroides fragilis. (1982) (47)
Persistent colonization by haemophilus influenzae in chronic obstructive pulmonary disease (2004) (47)
Sustainable Discovery and Development of Antibiotics - Is a Nonprofit Approach the Future? (2019) (47)
Cephalosporin-associated pseudomembranous colitis due to Clostridium difficile. (1979) (47)
Prevalence of acute enteric viral pathogens in acquired immunodeficiency syndrome patients with diarrhea (1989) (46)
Pilot study of a web-based antibiotic decision management guide. (2006) (46)
Clostridium difficile: Old and New Observations (2007) (46)
Azithromycin treatment failures in syphilis infections--San Francisco, California, 2002-2003. (2004) (45)
Screening for HIV (2005) (45)
Is activity against "atypical" pathogens necessary in the treatment protocols for community-acquired pneumonia? Issues with combination therapy. (2008) (44)
Recurrent pseudomembranous colitis unassociated with prior antibiotic therapy. (1981) (43)
Therapy for experimental intraabdominal sepsis: comparison of four cephalosporins with clindamycin plus gentamicin. (1977) (43)
Rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis: The foscarnet-ganciclovir cytomegalovirus retinitis trial (1997) (43)
Campylobacter pylori: fact or fancy? (1988) (43)
Diagnostic test for etiologic agents of community-acquired pneumonia (2004) (43)
Investigation of a ricin-containing envelope at a postal facility--South Carolina, 2003. (2003) (42)
New antimicrobial agents for patients with Clostridium difficile infections (2009) (42)
Clostridium difficile-associated enteric disease (2002) (41)
How to Pitch an Antibiotic Stewardship Program to the Hospital C-Suite (2016) (41)
Treatment of Clostridium difficile colitis. (1985) (41)
Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS: The cytomegalovirus retreatment trial (1996) (41)
Ultrastructural changes of cultured human amnion cells by Clostridiu difficile toxin (1979) (40)
ZIDOVUDINE-INDUCED NEUTROPENIA: ARE WE TOO CAUTIOUS? (1989) (40)
Factors associated with accelerated atherosclerosis in HIV-1-infected persons treated with protease inhibitors. (2003) (40)
Clostridium difficile infection: pathophysiology and diagnosis. (1997) (39)
Influenza A (H5N1): Will It Be the Next Pandemic Influenza? Are We Ready? (2005) (38)
Renal involvement in AIDS: sonographic-pathologic correlation. (1988) (38)
Detection of Clostridium difficile Infection (2010) (38)
The Johns Hopkins Hospital Guide to Medical Care of Patients With HIV Infection (1994) (37)
Antiretroviral therapy where resources are limited. (2003) (37)
Management of respiratory tract infections (1997) (37)
Tuberculosis and HIV infection: partners in human tragedy. (2007) (37)
Non-antibiotic-associated pseudomembranous colitis due to toxin-producing Clostridia. (1980) (37)
Comparison of five regimens for treatment of experimental clindamycin-associated colitis. (1978) (37)
Updated Guidelines for Use of Rifamycins for the Treatment of Tuberculosis Among HIV-Infected Patients Taking Protease Inhibitors or Nonnucleoside Reverse Transcriptase Inhibitors (2004) (37)
Role of Clostridium difficile in a case of nonantibiotic-associated pseudomembranous colitis. (1980) (37)
Apparent failure of chloramphenicol in the treatment of anaerobic infections. (1978) (36)
Mycobacterium chelonae infections associated with face lifts--New Jersey, 2002-2003. (2004) (36)
Risk of Cancer in People with AIDS (1999) (36)
Once-Daily Valacyclovir to Reduce the Risk of Transmission of Genital Herpes (2004) (36)
Principles of appropriate antibiotic use for treatment of acute respiratory tract infections in adults: background, specific aims, and methods. (2001) (35)
Commentary: Bartlett JG, Onderdonk AB, Cisneros RL, Kasper DL. Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters. J Infect Dis 1977; 136:701. (2004) (35)
Effectiveness of antiretroviral therapy among HIV-infected prisoners: Reincarceration and the lack of sustained benefit after release to the community (2004) (35)
Long-term combination antiretroviral therapy is associated with the risk of coronary plaques in African Americans with HIV infection. (2009) (34)
Tenofovir disoproxil fumarate in nucleoside-resistant HIV-1 infection (2004) (34)
Chronic diarrhea associated with Clostridium difficile in children. (1983) (34)
Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome (2004) (34)
Therapy of Antibiotic‐Associated Pseudomembranous Colitis (1979) (34)
Combination antiretroviral therapy in HIV infection. An economic perspective. (1996) (33)
Pneumonia in the patient with HIV infection. (1998) (32)
Death Due to Bioterrorism-Related Inhalational Anthrax (2001) (32)
Quantitative determination of the antibody response to the capsular polysaccharide of Bacteroides fragilis in an animal model of intraabdominal abscess formation. (1977) (32)
Human death associated with bat rabies--California, 2003. (2004) (32)
Comparative Effect of Tetracycline and Doxycycline on the Occurrence of Resistant Escherichia coli in the Fecal Flora (1975) (32)
Heat-denatured human immunodeficiency virus type 1 protein 24 antigen: prognostic value in adults with early-stage disease. (2002) (31)
Sexually transmissible infections other than HIV (2004) (31)
Predicting bacterial cause in infectious conjunctivitis: Cohort study on informativeness of combinations of signs and symptoms (2004) (30)
Treatment of infections associated with surgical implants (2004) (30)
Antiendotoxin monoclonal antibodies for gram-negative sepsis: guidelines from the IDSA. (1992) (30)
Host factors in the formation of abscesses. (1980) (30)
Intestinal parasites in a migrant farmworker population. (1986) (30)
Clostridium difficile infection. (2013) (30)
Smallpox vaccination and patients with human immunodeficiency virus infection or acquired immunodeficiency syndrome. (2003) (30)
Recent developments in the management of anaerobic infections. (1983) (30)
Empiric treatment with clindamycin and gentamicin of suspected sepsis due to anaerobic and aerobic bacteria. (1977) (30)
Treatment of Community-Acquired Pneumonia (2000) (29)
Empirical therapy of community-acquired pneumonia: macrolides are not ideal choices. (1997) (29)
Provisional guidance on the use of hepatitis C virus protease inhibitors for treatment of hepatitis C in HIV-infected persons. (2012) (29)
Stool desorbing activity: a possible cause of false-positive reactions in competitive enzyme immunoassays (1985) (28)
Impact of valve surgery on 6-month mortality in adults with complicated, left-sided native valve endocarditis: A propensity analysis (2004) (28)
GUIDELINES FROM THE INFECTIOUS DISEASES SOCIETY OF AMERICA Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults (27)
Peginterferon alfa-2a Plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-Co-infected persons (2004) (27)
Future Trends in Antimicrobial Chemotherapy: Expert Opinion on the 43rd ICAAC (2004) (26)
The clinical management and outcome of nail salon-acquired mycobacterium fortuitum skin infection (2004) (26)
Clinical, virologic, and immunologic response to efavirenz- or protease inhibitor-based highly active antiretroviral therapy in a cohort of antiretroviral-naive patients with advanced HIV infection (EfaVIP 2 study) (2004) (26)
Clostridium difficile infection: historic review. (2009) (26)
AIDS enteropathy. (1992) (26)
A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis (2004) (26)
Relative efficacy and critical interval of antimicrobial agents in experimental infections involving bacteroides fragilis. (1983) (25)
Failure to clear persistent vaccine-derived neurovirulent poliovirus infection in an immunodeficient man (2004) (25)
The impact of prophylaxis on outcome and resource utilization in Pneumocystis carinii pneumonia. (1995) (25)
Strain-specific immune response to haemophilus influenzae in chronic obstructive pulmonary disease (2004) (25)
Bacteroides bivius and Bacteroides disiens in obstetrical patients: clinical findings and antimicrobial susceptibilities (1980) (24)
Isolation of salmonella enterica serotype choleraesuis resistant to ceftriaxone and ciprofloxacin (2004) (24)
Management of influenza in adults older than 65 years of age: Cost-effectiveness of rapid testing and antiviral therapy (2004) (24)
Clostridium difficile-associated cecitis in guinea pigs exposed to penicillin. (1980) (24)
Improving HIV therapy. (1998) (24)
Antibacterial resistance leadership group: open for business. (2014) (24)
Fever in patients with HIV infection. (1996) (23)
Experimental aspects of intraabdominal abscess. (1984) (23)
Antimicrobial drug susceptibility of respiratory isolates of Hemophilus influenzae from adults. (1980) (23)
Prevalence and clinical symptoms of human metapneumovirus infection in hospitalized patients (2004) (23)
Laboratory diagnosis of urinary tract infections in adult patients (2004) (23)
Evaluation of a latex agglutination test for Clostridium difficile in two nursing home outbreaks (1989) (23)
Impact of the 1993 revision of the AIDS case definition on the prevalence of AIDS in a clinical setting (1993) (23)
The guide to living with HIV infection. (2006) (23)
Racial heterogeneity of HIV antigenemia in people with HIV infection. (1991) (22)
Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacterial in intensive care: A randomized controlled trial (2004) (22)
Bacterial infections of the pleural space. (1988) (22)
Comparison of 8 versus 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: A randomized trial (2004) (22)
Characterization of the pulmonary inflammatory response to an anaerobic bacterial challenge. (1986) (22)
Bezlotoxumab - A New Agent for Clostridium difficile Infection. (2017) (22)
Antibiotics in lung abscess. (1991) (21)
A Decade of HAART: The Development and Global Impact of Highly Active Antiretroviral Therapy (2008) (21)
When should antiretroviral therapy be started for HIV infection? Interpreting the evidence from observational studies (2004) (21)
Effect of new susceptibility breakpoints on reporting of resistance in Streptococcus pneumoniae--United States, 2003. (2004) (21)
IDCP GUIDELINES : MANAGEMENT OF UPPER RESPIRATORY TRACT INFECTIONS (1997) (20)
IMPACT OF NEW ORAL ANTIBIOTICS ON THE TREATMENT OF INFECTIOUS DISEASES (1993) (20)
HIV Seropositivity Predicts Longer Duration of Stay and Rehospitalization Among Nonbacteremic Febrile Injection Drug Users With Skin and Soft Tissue Infections (2008) (20)
Healthcare epidemiology: the current status of planning for pandemic influenza and implications for health care planning in the United States. (2008) (20)
Rapidly growing mycobacterial infections after pedicures (2004) (20)
Daptomycin, a new cyclic lipopeptide antibiotic, for the treatment of resistant gram-positive organisms (2004) (20)
Detection of Clostridium botulinum type B toxin in the presence of a lethal substance interfering with toxin neutralization. (1985) (20)
Seasonal and pandemic influenza: recommendations for preparedness in the United States. (2006) (20)
Clostridium difficile Infection. (2017) (20)
Pocketbook of infectious disease therapy (2004) (20)
No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: Randomized, double-blind, placebo-controlled trial (2004) (19)
Correlates of national HIV seroprevalence: An ecologic analysis of 122 developing countries (2004) (19)
Recovery of Campylobacter species from homosexual men. (1988) (19)
Outbreak of pseudomonas aeruginosa infections caused by commercial piercing of upper ear cartilage (2004) (19)
Pseudomembranous colitis associated with erythromycin. (1979) (19)
Fellowship training in infectious diseases: a report from the regional and national meetings of infectious diseases division chiefs and program directors. (1998) (19)
Zidovudine now or later? (1993) (19)
Virulence factors of anaerobic bacteria. (1982) (18)
The controversy regarding routine anaerobic blood cultures. (2000) (18)
Selective isolation and rapid identification of Clostridium botulinum types A and B by toxin detection (1985) (18)
Smallpox vaccination and the patient with an organ transplant. (2003) (17)
Applying lessons learned from anthrax case history to other scenarios. (1999) (17)
Atazanavir enhances saquinavir Hard-Gel concentrations in a ritonavir-boosted once-daily regimen (2004) (17)
Efficacy and safety of tenofovir df versus stavudine in combination therapy in antiretroviral-naive patients: A 3-year randomized trial (2004) (17)
Antibiotic administration in community-acquired pneumonia. (2004) (17)
Clostridium difficile and inflammatory bowel disease. (1981) (16)
The prognostic importance of changes in CD4+ cell count and HIV-1 RNA level in women after initiating highly active antiretroviral therapy (2004) (16)
Selective decontamination of the digestive tract and its effect on antimicrobial resistance. (1995) (16)
Changing trends in bacterial infections: Staphylococcus aureus, bacterial pneumonia, Clostridium difficile. (2007) (16)
Pseudomembranous enterocolitis: a review of its diverse forms. (1977) (16)
Prostatic abscesses involving anaerobic bacteria. (1978) (16)
Susceptibility ofAnaerobes toCefoxitin andOther Cephalosporins (1975) (16)
Anaerobic infections (third of three parts). (1974) (16)
Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi (2004) (15)
Anaerobic bacteria in suppurative infections of the male genitourinary system. (1981) (15)
Cardiac deaths after a mass smallpox vaccination campaign-New York City, 1947 (2004) (15)
Protease inhibitors for HIV infection. (1996) (15)
Accumulation of indium-111-labeled neutrophils and gallium-67 citrate in rabbit abscesses. (1986) (15)
RAPDI DIAGNOSIS OF ANAEROBIC INFECTIONS BY DIRECT GAS-LIQUID CHROMATOGRAPHY OF CLINICAL SPECIMENS (1976) (15)
Penicillin or clindamycin for primary lung abscess? (1983) (15)
Amikacin therapy for severe gram-negative sepsis: efficacy in infections involving gentamicin-resistant organisms. (1976) (15)
HIV-1 co/superinfection in intravenous drug users (2004) (15)
Aspergillosis update. (2000) (15)
Clinical presentation and bacteriologic analysis of infected human bites in patients presenting to emergency departments (2004) (14)
Pneumonia treatment process and quality. (2002) (14)
Update: Adverse events following civilian smallpox vaccination--United States, 2003. (2003) (14)
When to begin highly active antiretroviral therapy? Evidence supporting initiation of therapy at CD4 lymphocyte counts <350 cells/µL (2004) (14)
Relative Efficacy of β-Lactam Antimicrobial Agents in Two Animal Models of Infections Involving Bacteroides fragilis (1983) (14)
Leukocytosis and Clostridium difficile-associated diarrhea. (2000) (14)
THE IMPORTANCE OF CHLAMYDIA PNEUMONIAE AS A PATHOGEN: THE 1996 CONSENSUS CONFERENCE ON CHLAMYDIA PNEUMONIAE INFECTIONS (1997) (14)
Effects of irradiation on growth and toxigenicity of Clostridium botulinum types A and B inoculated onto chicken skins (1987) (13)
CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: The swiss cohort study (2004) (13)
Long-term antibiotic cost savings from a comprehensive intervention program in a medical department of a university-affiliated teaching hospital (2004) (13)
Evaluation of new anti-infective drugs for the treatment of acute pelvic infections in hospitalized women. Infectious Diseases Society of America and the Food and Drug Administration. (1992) (13)
Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome (2004) (13)
The Prevalence of Antiretroviral Drug Resistance in the United States (2004) (13)
Molecular impact of the M184V mutation in human immunodeficiency virus type 1 reverse transcriptase (2004) (13)
Enterovirus related metabolic myopathy: A postviral fatigue syndrome (2004) (12)
Kinetics of growth and toxigenicity of Clostridium botulinum in experimental wound botulism (1985) (12)
Predicting bacteremia in patients with community-acquired pneumonia (2004) (12)
Clinical pathways in an acute care setting: Community-acquired pneumonia (1996) (12)
Macrolide resistance in treponema pallidum in the United States and Ireland (2004) (12)
Bacteroides bivius and Bacteroides disiens in obstetrical patients: clinical findings and antimicrobial susceptibilities. (1981) (12)
Clinical pathways in an acute care setting: Community-acquired pneumonia (1996) (12)
Enzyme immunoassay for detection of antibody to toxins A and B of Clostridium difficile (1983) (12)
The Hopkins HIV Report (1999) (12)
Infection management during antileukemia treatment-induced granulocytopenia: the role for oral norfloxacin prophylaxis against infections arising from the gastrointestinal tract. (1986) (12)
Oral neomycin and erythromycin compared with single-dose systemic metronidazole and ceftriaxone prophylaxis in elective colorectal surgery. (1986) (11)
Role of Anaerobic Bacteria in Perimandibular Space Infections (1991) (11)
Increase in viral gastroenteritis outbreaks in europe and epidemic spread of new norovirus variant (2004) (11)
Penicillin for acute sore throat in children: Randomized, double blind trial (2004) (11)
Prolonged treatment interruption after immunologic response to highly active antiretroviral therapy (2004) (11)
Workshop on clinical trials of antibacterial agents for hospital-acquired pneumonia and ventilator-associated pneumonia. (2010) (11)
A randomized trial of 2 different 4-drug antiretroviral regimens versus a 3-drug regimen in advanced human immunodeficiency virus disease (2004) (11)
Antibiotic-associated diarrhea accompanied by large-scale alterations in the composition of the fecal microbiota (2004) (11)
Loss of HIV-1-specific immunity during treatment interruption in 2 chronically infected patients. (2002) (11)
Update on diagnosis of Clostridium difficile-associated diarrhea. (1995) (11)
Performance evaluation in multicenter clinical trials: development of a model by the AIDS Clinical Trials Group. (1992) (11)
Letter: Bacteremia after sigmoidoscopy: another view. (1976) (11)
Combination Antiretroviral Therapy in HIV Infection (1996) (11)
Vitamin D Deficiency is Associated With the Development of Subclinical Coronary Artery Disease in African Americans With HIV Infection (2012) (11)
Toxicity of antiretroviral agents. (1999) (10)
Screening for hepatitis C virus infection in adults: Recommendation statement (2004) (10)
Differential time to positivity: A useful method for diagnosing catheter-related bloodstream infections (2004) (10)
Weekly report: Influenza summary update (2004) (10)
Comparative full length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infections (2004) (10)
Emergency of community-acquired methicillin-resistant staphylococcus aureus (2004) (10)
A 48-week duration of therapy with pegylated interferon a2b plus ribavirin may be too short to maximize long-term response among patients infected with genotype-1 hepatitis C virus (2004) (10)
Priorities for the treatment of latent tuberculosis infection in the united States (2004) (10)
False-positive gonorrhea test results with a nucleic acid amplification test: The impact of low prevalence on positive predictive value (2004) (10)
Inhibition of binding of Clostridium difficile toxin by steroids. (1980) (10)
An animal model of intra-abdominal sepsis. (1979) (10)
New guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. (2001) (9)
Lack of recurrence of hyperlactatemia in hiv-infected patients switched from stavudine to abacavir or zidovudine (2004) (9)
Structured treatment interruption in patients with multidrug-resistant human immunodeficiency virus (2004) (9)
Destroying the life and career of a valued physician-scientist who tried to protect us from plague: was it really necessary? (2005) (9)
Treatment of anaerobic pulmonary infections. (1989) (9)
The 10 most common questions about clostridium difficile–associated diarrhea/colitis (1992) (9)
Incidence and predictors of severe liver fibrosis in human immunodeficiency virus-infected patients with chronic hepatitis C: A European collaborative study (2004) (9)
Anaerobic bacterial pleuropulmonary infections (1992) (8)
A roundtable discussion of antibiotic resistance: Putting the lessons to work (1999) (8)
Clinical features and diagnosis of anaerobic pleuropulmonary infections. (1970) (8)
Amikacin treatment of pulmonary infections involving gentamicin-resistant gram-negative bacilli. (1977) (8)
Ethical dilemmas in continuing a zidovudine trial after early termination of similar trials. (1993) (8)
Safety and Efficacy of zidovudine in asymptomatic HIV infected individuals withless than 500 CD4+ cells/mm3. (1990) (8)
Association between oral fluoroquinolones and retinal detachment. (2012) (7)
Effect of Amoxicillin-Clavulanate in Clinically Diagnosed Acute Rhinosinusitis (2004) (7)
Comprar A Decade of HAART The Development and Global Impact of Highly Active Antiretroviral Therapy | José M Zuniga | 9780199225859 | Oxford University Press (2008) (7)
Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands (2004) (7)
Kinetics study of immunological response to Clostridium botulinum toxin (1987) (7)
Experimental studies of antibiotic associated colitis. (1980) (7)
Lactic Acidemia in Infection with Human Immunodeficiency Virus (2004) (7)
Testing for HIV infection: recommendations for surgeons. (1988) (7)
Evaluation of new anti-infective drugs for the treatment of acute pelvic inflammatory disease. Infectious Diseases Society of America and the Food and Drug Administration. (1992) (7)
Management of hepatitis C: a review of the NIH Consensus Development Conference. (2002) (7)
Paradox of antibiotic treatment of antibiotic-associated diarrhea. (1978) (7)
Rickettsia parkeri: A newly recognized cause of spotted fever rickettsiosis in the united states (2004) (6)
Body habitus changes related to lipodystrophy (2004) (6)
The Guide to Living with HIV Infection: Developed at the Johns Hopkins AIDS Clinic (1991) (6)
Methicillin-resistant Staphylococcus aureus infections. (2008) (6)
The ABX guide : diagnosis & treatment of infectious diseases (2005) (6)
The protease inhibitor lopinavir-ritonavir may produce opiate withdrawal in methadone-maintained patients (2004) (6)
Recent developments in the management of herpes simplex virus infection in HIV-infected persons. (2004) (6)
Dangerous pathogens in the laboratory: From smallpox to today’s sars setbacks and tomorrow’s polio-free world (2004) (6)
HIV infection and surgeons. (1992) (6)
Collaborative multidisciplinary workshop report: clinical antimicrobial trials for primary and secondary prevention of atherosclerotic cardiovascular disease. (2000) (6)
14 – Respiratory Tract and Other Thoracic Infections (1989) (6)
Use of the computer program GIDEON at an inpatient infectious diseases consultation service. (2006) (6)
A comprehensive plan for managed care of patients infected with human immunodeficiency virus. (1999) (6)
Bacteriologic diagnosis in anaerobic pleuropulmonary infections. (1993) (6)
Severe acute pneumonitis among deployed U.S. military personnel--Southwest Asia, March-August 2003. (2003) (6)
2004 Health Update #5: Surveillance for Transmissible Spongiform Encephalopathies, including the Classic and Variant Forms of Creutzfeld-Jakob Disease, in New York City (2004) (6)
Update in Infectious Diseases (1998) (6)
Anaerobic infections of the pelvis. (1979) (6)
The DHHS adult ART guidelines are revised. (2005) (6)
CHAPTER 17 – Pseudomembranous Colitis (1983) (6)
Effect of prolonged discontinuation of successful antiretroviral therapy on CD4 T cells: A controlled, prospective trial (2004) (6)
Why Infectious Diseases (2014) (6)
Challenges in the management of serious infections. (2006) (5)
Assessment of response to antimicrobial therapy and time to discharge in patients hospitalized with community-acquired pneumonia (1996) (5)
Antibiotic-associated diarrhea. Article three in the series (1992) (5)
New guidelines for management of dyslipidemia from IDSA and the ACTG. (2004) (5)
Epidemiology, clinical manifestations, and diagnosis of Cryptococcus neoformans meningoencephalitis in HIV-infected patients Authors (2016) (5)
Community‐acquired bacterial infections (1989) (5)
Bartlett's Medical Management of HIV Infection (2019) (5)
Human immunodeficiency virus/AIDS Medicaid managed care network. (1997) (5)
Clostridium difficile in elderly patients. (1989) (5)
International HIV Workshop on Management of Treatment-Experienced Patients. (2002) (5)
Colonisation with digoxin-reducing strains of Eubacterium lentum and Clostridium difficile infection in nursing home patients. (1992) (5)
Combined Jejunal and Colonic Fecal Bacteriotherapy in Patients with Recurrent Clostridium Difficile Infection (RCDI): 415 (2011) (5)
Infection rate disclosure battle in PA may foretell struggle in other states (2004) (5)
The effect of corticosteroids on subcutaneous abscess formation in the mouse. (1981) (5)
Investigation of infection control practices and knowledge of hepatitis C among body-piercing practitioners (2004) (5)
Relative rates of non-pneumonic sars coronavirus infection and SARS coronavirus pneumonia (2004) (5)
Cultivation of tropheryma whipplei from cerebrospinal fluid (2004) (5)
Guideline tyranny: a response to the article by Baum and Kaltsas. (2008) (5)
Patient’s death from vCJD may be linked to blood transfusion (2004) (5)
The 2003/2004 Southern African abbreviated guide to medical management of HIV infection. (2003) (4)
Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy (2004) (4)
How to identify the cause of antibiotic-associated diarrhea. (1994) (4)
Contribution of a urinary antigen assay (binax NOW) to the early diagnosis of pneumococcal pneumonia (2004) (4)
Mobilizing Professional Communities (2001) (4)
High levels of adherence do not prevent accumulation of HIV drug resistance mutations (2004) (4)
Identification of toxigenic Clostridium botulinum type E by enzyme immunoassay. (1991) (4)
The biological and clinical significance of Clostridium difficile. (1981) (4)
Global infectious diseases and urbanization. (2010) (4)
Reply to Wargo and Eiland (2005) (4)
Integrating Nutrition Therapy into Medical Management of Human Immunodeficiency Virus (2003) (4)
New developments in infectious diarrhea. (1986) (4)
Six-year follow-up of HIV-1-infected adults in a clinical trial of antiretroviral therapy with indinavir, zidovudine, and lamivudine (2004) (3)
Human cervicofacial actinomycoses: Microbiological data for 1997 cases (2004) (3)
Rape and subsequent seroconversion to HIV. (1989) (3)
Neutralization of staphylococcus aureus panton valentine leukocidin by intravenous immunoglobulin in vitro (2004) (3)
Comparative efficacy of ceftriaxone in experimental infections involving Bacteroides fragilis and Escherichia coli. (1993) (3)
Updated Guidelines for Managing HIV in Pregnancy from the USPHS Task Force (2001) (3)
New developments in infectious diseases for the critical care physician (1983) (3)
Access to antiretroviral therapy. (2000) (3)
An outbreak of escherichia coli 0157 infection following exposure to a contaminated building (2004) (3)
Therapeutic trial of moxalactam in intra-abdominal sepsis and gynaecological infections (1982) (3)
Workshop on Issues in the Design of Clinical Trials for Antibacterial Drugs for Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia (2010) (3)
Anaerobic pleuropulmonary infections. Clinical considerations. (1975) (3)
Infectious diseases continued. (1992) (3)
Blood exposures and hepatitis C virus infections among emergency responders (2004) (3)
Update on management of opportunistic infections in patients with HIV infection (1993) (3)
Clinical Practice. Acute Infectious Diarrhea (2004) (3)
Antiretroviral therapy in patients with HIV infection (1996) (3)
Protease inhibitors, a new class of HIV therapy (1997) (3)
Antibiotic resistance. (1995) (3)
Infectious diseases associated with natural disasters (2008) (3)
Age distribution for T cell reactivity to vaccinia virus in a healthy population (2004) (3)
Experimental Intra-Abdominal Sepsis (1976) (3)
Treatment of postoperative pulmonary infections. (1975) (3)
Questions about Q fever. (2000) (3)
Zidovudine intolerance. Discussion (1990) (3)
Community-acquired pneumonia: Current status (1995) (3)
Consensus on early intervention in community-acquired pneumonia: Panel discussion (1996) (2)
Significant challenges facing HIV practitioners. (2008) (2)
Management of patients with asymptomatic HIV infection. (1990) (2)
Respiratory infections in the community: evaluating current antibiotic options. Introduction. (2010) (2)
Absolute CD4 versus CD4 percentage for predicting the risk of opportunistic illness in HIV infection (2004) (2)
Complications of HIV therapy. (2000) (2)
Appropriate Use of Antibiotics: Success of Current Strategies and Future Directions (2006) (2)
CDC/HRSA/NIH/HIVMA of the IDSA recommendations for incorporating HIV prevention into the medical care of HIV-infected persons (2004) (2)
Second national AIDS malignancy conference. (1999) (2)
Clostridium difficile and cytotoxin in feces of patients with antimicrobial agent-associated pseudomembranous colitis: Comment on the report by W. L. George et al. (1982) (2)
Human immunodeficiency virus infection. (1993) (2)
Increasing prevalence of methicillin-resistant staphylococcus aureus infection in California jails (2004) (2)
AIDS enteropathy [2] (1991) (2)
ACOG committee opinion. "Scheduled cesarean delivery and the prevention of vertical transmission of HIV infection" [ACOG committee opinion #219, August 1999]. (1999) (2)
Effects of alpha interferon induction plus ribavirin with or without amantadine in the treatment of interferon non-responsive chronic hepatitis C: A randomized trial (2004) (2)
AN UPDATE ON MIXED AEROBIC AND ANAEROBIC INFECTIONS (2002) (2)
Reply to Collins et al. and to Singh (2007) (2)
Introduction: Routine Opt-Out HIV Testing: Rationale for the Consensus Conference and this Supplement. (2007) (2)
Extraneural pathologic prion protein in sporadic creutzfeldt-jakob disease (2004) (2)
Update in Infectious Diseases (1999) (2)
Deep salvage with amprenavir and lopinavir/ritonavir: Correlation of pharmacokinetics and drug resistance with pharmacodynamics (2004) (2)
Guidelines for selection of anti-infective agents for complicated intra-abdominal infections (2004) (2)
Methods to detect bacterial pathogens in pneumonia (1984) (2)
Infections of the large intestine (1989) (2)
General discussion: Postexposure prophylaxis (1997) (2)
Managing community-acquired pneumonia (2001) (2)
Treating foot infections in diabetic patients: A randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate (2004) (2)
Virulence factors of anaerobic bacteria: summary of the symposium. (1979) (2)
Baseline HIV-1 RNA level and CD4 cell count predict time to loss of virologic response to nelfinavir, but not lopinavir/ritonavir, in antiretroviral therapy-naive patients (2004) (2)
Prognostic importance of initial response in HIV-1-infected patients starting potent antiretroviral therapy: Analysis of prospective studies (2004) (2)
The clinical significance of macrolide-resistant streptococcus pneumoniae; it’s all relative (2004) (2)
CLOSTRIDIUM DIFFICILE AND PSEUDOMEMBRANOUS COLITIS IN HUMANS (1980) (2)
Re-emergence of fatal human influenza a subtype H5N1 disease (2004) (2)
Clostridium difficile-associated (2002) (2)
Efficacy of moxalactam in an animal model of subcutaneous abscesses: penetration into infected sites and in vivo activity against Bacteroides fragilis. (1982) (2)
Diagnosis of Clostridium difficile Colitis (1996) (2)
Report from IDSA: symposium on healthcare worker issues. (2000) (2)
Decision Making in Surgical Sepsis (1991) (2)
Progress toward global eradication of dracunculiasis, January-June 2003 (2004) (2)
GUIDELINES SECTION (2000) (2)
New guidelines for antiretroviral therapy from the IAS--USA and DHHS. (2000) (2)
Randomized double-blind study comparing 3- and 6-day regimens of azithromycin with a 10-day amoxicillin-clavulanate regimen for treatment of acute bacterial sinusitis (2004) (2)
Anaerobic lower respiratory tract infections. (1981) (2)
Pathogenesis and Treatment of Pseudomembranous Enterocolitis (1986) (1)
AIDS in India. (1995) (1)
The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections (2004) (1)
Failure of penicillin in experimental Bacteroides fragilis infections (1975) (1)
Guidelines for treatment of candidiasis (2004) (1)
IDCP GUIDELINES : MANAGEMENT OF HIV INFECTION (1997) (1)
Collaborative multidisciplinary workshop report (2000) (1)
Respiratory infections: Editorial overview (1989) (1)
Clostridium difficile: a new enteric pathogen. (1980) (1)
Resistance in Anaerobic Bacteria: Worrisome Developments (2004) (1)
Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss General Population (2004) (1)
Evaluation of the rapid immunoassay determine HIV1/2 for detection of antibodies to human immunodeficiency virus types 1 and 2 (2004) (1)
Real-time PCR assay to detect smallpox virus (2004) (1)
Metaanalysis of cephalosporins versus penicillin for treatment of group a streptococcal tonsillopharyngitis in adults (2004) (1)
Communications to the EditorThe Effect of Prophylaxis on the Outcome of HIV-Associated Pneumocystis carinii Pneumonia (1996) (1)
Adequacy of early empiric antibiotic treatment and survival in severe sepsis: Experience from the MONARCS trial (2004) (1)
Cytomegalovirus infection in immunocompetent patients (2004) (1)
HIV/AIDS managed care program. (2000) (1)
USPHS updates occupational HIV post-exposure prophylaxis guidelines. (2006) (1)
FDA approves Pegasys and Copegus for hepatitis C in patients with HIV co-infection. (2005) (1)
Incidence of resistance in a double-blind study comparing lopinavir/ritonavir plus stavudine and lamivudine to nelfinavir plus stavudine and lamivudine (2004) (1)
Vancomycin-resistant enterococci at Johns Hopkins Hospital (1996) (1)
Management of Opportunistic Infections in Patients with HIV Infection: Update (1994) (1)
Editorial: Anaerobic infections: old myths and new realities. (1974) (1)
HIV: twenty years in review. (2001) (1)
Panel on clinical practices issues revised adult ART guidelines. (2003) (1)
Reply to Tillotson, Outterson et al, and Burgess et al (2010) (1)
Long-term efficacy of routine access to antiretroviral-resistance testing in HIV Type 1-infected patients: Results of the clinical efficacy of resistance testing trial (2004) (1)
Reply to Yu et al. (2004) (1)
Diagnostic value of microscopic examination of gram-stained sputum and sputum cultures in patients with bacteremic pneumococcal pneumonia (2004) (1)
Public health service task force updates recommendations for use of antiretroviral drugs in pregnant women. (2000) (1)
Accuracy of screening for inhalation anthrax after a bioterrorist attack (2004) (1)
Management of community-acquired pneumonia: An appropriate-use tool (2001) (1)
Fever of unknown origin in patients infected with human immunodeficiency virus (1996) (1)
MMR vaccine and autism: An update of scientific evidence (2004) (1)
Practical Guide to Anaerobic Bacteriology (1978) (1)
Point of View: Planning Ahead (1987) (1)
HIV Managed Care in the Maryland Health Choice Program (2001) (1)
Editorial: A Prospectus (2004) (1)
Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection (2004) (1)
DHHS Issues Adult Guideline Revisions (2004) (1)
2002 Pocket book of infectious disease therapy (2013) (1)
HIV in Resource-Limited Settings (2019) (1)
Clinical and economic consensus on early intervention in community-acquired pneumonia (1996) (1)
Resistant HIV Strains Often Show Cross-Resistance to New Drugs (1999) (1)
Preventive treatment in human immunodeficiency virus infection: Vaccinations (1996) (1)
Partial Purification and Characterization of a Cytotoxin (1979) (1)
Nasal Carriage of Staphylococcus aureus (2000) (1)
Natural History and Classification (2019) (1)
Evaluation of control measures implemented in the severe acute respiratory syndrome outbreak in Beijing, 2003 (2004) (1)
Cost-Effectiveness of Postexposure Prophylaxis After Sexual or Injection-Drug Exposure to Human Immunodeficiency Virus (2004) (1)
Expression of human herpesvirus 8 in primary pulmonary hypertension (2004) (1)
Reply to Kunin: Rationale for Antibiotic Development Incentives (2008) (1)
Treatment of opportunistic infections. (2004) (1)
Early versus delayed zidovudine in the management of HIV infection (1994) (1)
Introduction. Integrating nutrition therapy into medical management of human immunodeficiency virus. (2003) (1)
Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with high-dose VZV vaccine (2004) (1)
Antiretroviral Therapy In HIV-Infected Patients: Update (1994) (1)
Early Intervention in Community-Acquired Pneumonia (1996) (0)
Treatment of the naive patient. (1999) (0)
Infectious Diseases: Lessons From Our History (2004) (0)
Profiles on New Drugs (2004) (0)
Quantification of the influenza virus load by real-time polymerase chain reaction in nasopharyngeal swabs of patients treated with oseltamivir (2004) (0)
Anaerobic Bacterial Pneumonitis 1, 2 (2015) (0)
Internal Medicine: Infectious Diseases (1982) (0)
Chapter 25 – Other HIV-related pneumonias (2012) (0)
Laboratory Tests (2019) (0)
Atypical and Legionella infections (1989) (0)
THE 10 MOST COMMON QUESTIONS ABOUT PROTEASE INHIBITORS (1997) (0)
Smallpox vaccination and the patient with HIV/AIDS. (2003) (0)
Current challenges in the treatment of respiratory tract infections : role of the fluoroquinolones (1997) (0)
HIV infection and AIDS. (2009) (0)
Community-acquired pneumonia guidelines, Part 4: Special therapeutic considerations (1998) (0)
Recommendations for HIV-positive inmates. (2001) (0)
RESISTANCE : EFFECTIVENESS OF CURRENT INTERVENTIONS — (2006) (0)
Prevention of Opportunistic Infections in Human Immunodeficiency Virus-Infected Patients (1994) (0)
New drugs (2001) (0)
Top ten publications of 2001. (2002) (0)
Report on HIV/AIDS from IDSA: news from the mile high city. (1999) (0)
Didanosine and zalcitabine in the treatment of AIDS (1994) (0)
Increased risk of achilles tendon rupture with quinolone antibacterial use, especially in elderly patients taking oral corticosteroids (2004) (0)
Clinical practice. Cellulitis (2004) (0)
Do resident physicians use antibiotics appropriately in treating upper respiratory infections? A survey of 11 programs (2004) (0)
Effect of Zidovudine (AZT) Postexposure Prophylaxis on the Development of HIV-Specific Cytotoxic T-Lymphocyte Response in HIV-Exposed Health Care Workers (1999) (0)
Streptococcus pneumoniae as a Cause of Community-Acquired Pneumonia: Changes Over the Past 100 Years (2017) (0)
The detection of monkeypox in humans in the western hemisphere (2004) (0)
A randomized trial of chinese herbal medicines for the treatment of symptomatic hepatitis C (2004) (0)
The Increasing Resistance of Gram-Negative Bacilli (2009) (0)
Rapid identification of Clostridium botulinum colonies by in vitro toxicity and antimicrobial susceptibility testing (1994) (0)
Revised guidelines for prevention of opportunistic infections (1997) (0)
CDC Recommendations for Opt-Out HIV Testing—Reply (2009) (0)
3TC: drug du jour for AIDS (1995) (0)
Antimicrobial Drug Resistance Update. (2005) (0)
HIV Care Delivery (1999) (0)
Tuberculosis is a thriving industry (1995) (0)
Testing for competence in HIV care. (2003) (0)
Genetic Risk Assessment and BRCA Mutation Testing (0)
Prion disease: A summary based on the following sources (2004) (0)
DHHS guidelines: the most recent revisions. Department of Health and Human Services. (1998) (0)
EARLY TREATMENT OF HIV-1 INFECTION. AUTHOR'S REPLY (1998) (0)
IVIG for Streptococcal Toxic Shock Syndrome (2000) (0)
CDC Recommendations for Hepatitis C Virus Testing (1999) (0)
Atazanavir: clinical use. (2003) (0)
Update on opportunistic infections. (2000) (0)
Notes on medical management of human immunodeficiency virus infections recommended antiretrovorial therapy (1999) (0)
Replacement of protease inhibitors by nevirapine or efavirenz in simplification and rescue interventions: Which works better? (2004) (0)
Bravehearts - crystal ball: antibiotic resistance - of lice, cats, and men (1997) (0)
AZT for needlestick injuries (1995) (0)
Update in Infectious Diseases (1997) (0)
Hepatitis B virus infection-natural history and clinical consequences (2004) (0)
Report from ICAAC: update on opportunistic infections. (2002) (0)
How does expert advice impact genotypic resistance testing in clinical practice (2004) (0)
How to use the newest anti-HIV drugs (1994) (0)
Clostridium difficile: A personal perspective (1997) (0)
Developments in opportunistic infections from IDSA and ICAAC 2000. (2000) (0)
Multistate evaluation of invasive pneumococcal diseases in adults with human immunodeficiency virus infection: Serotype and antimicrobial resistance patterns in the United States (2004) (0)
Biologic activity of chloramphenicol in experimental intraabdominal sepsis (1978) (0)
Clostridium difficile Colitis (2015) (0)
West Nile virus activity--United States, November 13-19, 2003. (2003) (0)
Immune reconstitution hepatitis in HIV and hepatitis B coinfection, despite lamivudine therapy as part of HAART (2004) (0)
1994 Pocket book of infectious diseases therapy (2015) (0)
The ethics of personal stockpiles. Author's reply (2006) (0)
Anaerobic infections of the lower airways (1984) (0)
Two “HIV-infected” persons not really infected (2004) (0)
NOTES ON MEDICAL MANAGEMENT OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION POSTEXPOSURE PROPHYLAXIS FOR HEALTH CARE WORKERS (1998) (0)
Influenza vaccine enlisted to prevent SARS confusion (2004) (0)
Assessment of nutritional status, body composition, and human immunodeficiency virus-associated morphologic changes (2004) (0)
Increasing Antibiotics Lowers Resistance (1999) (0)
Update on Department of Health and Human Services guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. (1999) (0)
Summary of the 5th Conference on Retroviruses and Opportunistic Infections. (1998) (0)
REVIEW OF AIDS LITERATURE (2000) (0)
Update on complications of HAART from ICAAC and the 2nd International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV. (2000) (0)
Herpes virus infections, HIV, and disease progression. Recommended, not required. (1995) (0)
A publication of the International AIDS Society–USA Perspectives Changing Trends in Bacterial Infections: Staphylococcus 94 aureus, Bacterial Pneumonia, Clostridium diffi cile (2007) (0)
Outbreak notice: Avian influenza cases, Vietnam (2004) (0)
Antimicrobial probes in experimental ulcerative colitis: protection with metronidazole (1977) (0)
Decline in Hospital Use for Patients with HIV from 1995 to 1997 (1999) (0)
Understanding Antimicrobial Exposure and Clostridium difficile Infection: Implications of Fluoroquinolone Use (2008) (0)
Pneumonia treatment process and quality [3] (2002) (0)
Current Opinion in the Treatment of Community-Acquired Pneumonia: Results of the Presymposium Interactive Question and Answer Session (2000) (0)
Infectious diseases. (1997) (0)
Conference news at a glance. (1998) (0)
New intestinal pathogens. (1986) (0)
Report on new drugs. (2000) (0)
Comments on new recommendations for occupational exposure to HIV (1996) (0)
Product information. (1998) (0)
DHHS issues adult guideline revisions. (2004) (0)
3rd IAS conference: prevention highlights. (2005) (0)
The Decline in the Development of Antibacterial and Other Antimicrobial Agents: How Can We Counter An Emerging Health Crisis? (2004) (0)
NOTES ON MEDICAL MANAGEMENT OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION LABORATORY TESTS (1998) (0)
IDCP Snapshots (1996) (0)
Drug profile: Fosamprenavir (lexiva) (2004) (0)
Public Health Declines in the Former Soviet Union, Along with the Stock Market (1998) (0)
Amikacin Therapy for Severe Gram-Negative Sepsis (2020) (0)
The inexact science of influenza prediction (2004) (0)
Long-term efficacy, safety, and tolerability of indinavir-based therapy in protease inhibitor-naïve adults with advanced HIV infection (2004) (0)
ID Clinical Science (2016) (0)
Reply to Horowitz. (2018) (0)
New Study Suggests HIV Persists for Life (1999) (0)
The Future is Now: Challenges and Opportunities in Infectious Disease (2010) (0)
Risk factors for severe respiratory virus infection in elderly persons (2004) (0)
B101 Ten draconian changes in HIV care for 2013 (2013) (0)
Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome (2004) (0)
Advances and controversies in the treatment of HIV (2005) (0)
Infections Diseases in South America (1998) (0)
CD4 Cell Response to 3 Doses of Subcutaneous Interleukin 2: Metaanalysis of 3 Vanguard Studies (2004) (0)
Development of an endothelium/smooth muscle cell bi-layer model to investigate the pathogenesis of Chlamydia pneumoniae in human vascular cells (2000) (0)
Antimicrobial - associated gastroenteritis (1980) (0)
Treating severe bacterial and fungal infections: The ongoing search for optimal first-line strategies (2004) (0)
Editorial comment: the need for alternative credentialing system for HIV. (2006) (0)
Detection of Prosthetic Hip Infections at Arthroplasty (2000) (0)
What's Hot in ID and HIV Medicine (2009) (0)
Serology and baseline laboratory studies for human immunodeficiency virus infection (1995) (0)
Update in Infectious Diseases (2000) (0)
Levels During Continuous Cultivation (0)
The risk of human immunodeficiency virus-1 infection in twin pairs born to infected mothers in Africa (2004) (0)
Smallpox vaccination and HIV infection. (2003) (0)
What's Hot in Infectious Diseases (2006) (0)
Clostridium infections associated with musculoskeletal-tissue allografts (2004) (0)
Updates to DHHS guidelines (1998) (0)
Does Clean Surgery Need Antibiotic Prophylaxis (1999) (0)
Etiology of clinical proctitis among men who have sex with men (2004) (0)
Anatomical loci of HIV-associated immune activation and association with viraemia (2004) (0)
Resistant pneumococci strike home (1995) (0)
Bacteriology and infection: Good antimicrobial prescribing (1983) (0)
Immunoproliferative small intestinal disease associated with campylobacter jejuni (2004) (0)
Infection Management (2019) (0)
Antiretroviral guidelines updates (1998) (0)
Culture of troopheryma whipplei from human samples: A 3-year experience (1999-2002) (2004) (0)
Influenza burden of illness: Estimates from a national prospective survey of household contacts in France (2004) (0)
From the Infectious Disease Board, American Board of Internal Medicines (1992) (0)
Randomized trial to evaluate indinavir/ritonavir versus saquinavir/ritonavir in human immunodeficiency virus type 1-infected patients: The maxcmin1 trial (2004) (0)
Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: A randomized controlled trial (2004) (0)
Recommendations for treatment of human infections caused by bartonella species (2004) (0)
Collection of Tracheobronchial Secretions (1974) (0)
Streptococcal Necrotizing Fasciitis—Clindamycin? IVIG? (2000) (0)
What's Hot in ID Clinical Science (2014) (0)
Office treatment of anaerobic infections. (1977) (0)
New opportunities to optimize antimicrobial treatment. (2001) (0)
Updated guidelines for managing HIV in pregnancy from the USPHS Task Force. (2001) (0)
Delayed onset of malaria-implications for chemoprophylaxis in travelers (2004) (0)
Tuberculosis in Baltimore: Accolade to David Glasser (1995) (0)
Update from the 8th CROI: adverse effects of HAART and structured treatment interruption. (2001) (0)
Prevention of HIV and Prevention of Infection in PLWH (2019) (0)
Dupont pharmaceuticals study 006 for Sustiva. (1998) (0)
Rifampin as Adjunctive Treatment of Orthopedic Implant Infections (1998) (0)
Bacterial infections: initial therapy guidelines (1974) (0)
HIV-associated neuromuscular weakness syndrome (2004) (0)
Anergy testing is no longer clearly recommended for patients with human immunodeficiency virus infection (1995) (0)
Bezlotoxumab and Recurrent Clostridium difficile Infection. (2017) (0)
Case series of acute hepatitis in a non-selected group of HIV-infected patients on nevirapine-containing antiretroviral treatment (2004) (0)
Flying with TB (1995) (0)
EFFECT OF ANTIBIOTICS ON SALMONELLA INTESTINAL INFECTIONS-NEW STUDY SUGGESTS HIV PERSISTS FOR LIFE-RESISTANT HIV STRAINS OFTEN SHOW CROSS-RESISTANCE T O NEW DRUGS-DISCONTINUATION OF PCP PROPHYLAXIS FOLLOWING HAART IS SUCCESSFU L-INCREASING ANTIBIOTICS LOWERS RESISTANCE ? (1999) (0)
Infection control in the nineties: Spreading our tentacles (1999) (0)
DIAGNOSIS OF CLOSTRIDIUM DIFFICILE COLITIS. AUTHORS' REPLY (1996) (0)
A-106 HIV Infection: Whatʼs new novel and exciting (2016) (0)
Estimates and Mechanisms of Transmission of Human Immunodeficiency Virus in the United States (1994) (0)
The inventory of antibiotics in russian home medicine cabinets (2004) (0)
Evaluation ofa LatexAgglutination TestforClostridium difficile in TwoNursing Home Outbreaks (1989) (0)
Consensus among Participants for the Treatment of Community-Acquired Pneumonia: Results of the Postsymposium Interactive Question and Answer Session (2000) (0)
Expert Professors What do ID physicians really think about the microbiology lab (2008) (0)
Evaluation of antimicrobial agents in animal models of infections involving bacteroides fragilis (1985) (0)
The Jeremiah Metzger Lecture: avian influenza. (2006) (0)
The Growing Threat of Resistance in Anti-infective Medicine (2006) (0)
Lyme disease. (1989) (0)
Contributors (2012) (0)
The relationship among previous antimicrobial use, antimicrobial resistance, and treatment outcomes for helicobacter pylori infections (2004) (0)
Recognition and Treatment of Antibiotic-Associated Colitis (1983) (0)
Hot Topics in Infectious Diseases (2007) (0)
Late breaking news: two additional DHHS guidelines changes. Department of Health and Human Services. (1998) (0)
Diarrhea Due to S. aureus (2000) (0)
Discontinuation of PCP Prophylaxis Following HAART Is Successful (1999) (0)
Virulence Factors of Anaerobic Bacteria: Summary (1979) (0)
Interlaboratory reliability of microimmunofluorescence test for measurement of chlamydia pneumoniae-specific immunologlobulin a and g antibody titers (2004) (0)
CDC Redefines Pencillin-Resistant S. Pneumoniae (1999) (0)
Community-acquired pneumonia guidelines, Part 2: Which diagnostic studies to use, and when (1998) (0)
Attempting to avoid antibiotic resistance : lessons for the primary care physician : proceedings of a symposium (1999) (0)
Update on opportunistic infections. (2000) (0)
Raising the bar in the care of patients with HIV: Expanding treatment strategies and limiting transmission (2006) (0)
Pleural Empyema/Lung Abscess in the Critical Care Unit (2016) (0)
1993 Pocket Book Of Infectious Disease Therapy (1993) (0)
Emerging Treatments for Resistant Bacterial Infections and Pathogen-Focused Therapy (2008) (0)
AIDS ENTEROPATHY. AUTHOR'S REPLIES (1991) (0)
Clinical Infectious Disease: Antibiotic-Associated Diarrhea (2008) (0)
Antibiotic use in relation to the risk of breast cancer (2004) (0)
The impact of hepatitis C virus coinfection on HIV progression before and after highly active antiretroviral therapy (2004) (0)
Systems Review (2019) (0)
Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: A 12-year cohort study (2004) (0)
PANDEMIC INFLUENZA: A CALL TO ACTION* (2007) (0)
TB in a High School (1995) (0)
Community-acquired pneumonia guidelines: Part 1: Assessing your patient's risk (1998) (0)
Community-acquired pneumonia guidelines, Part 3: Choosing antimicrobial therapy (1998) (0)
In the wings: Ketolides against gram-positive cocci (1998) (0)
Interactive symposium on HIV care. (1998) (0)
Improvement in lipoatrophy associated with highly active antiretroviral therapy in human immunodeficiency virus-infected patients switched from stavudine to abacavir or zidovudine: The results of the TARHEEL study (2004) (0)
Causes and factors associated with early failure in hospitalized patients with community-acquired pneumonia (2004) (0)
QEP Development Committee (2009) (0)
Screening for HIV. Authors' reply (2005) (0)
HCFA plans for home care (1995) (0)
The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis (2004) (0)
FDA Approves Shortest Treatment for Helicobacter pylori (1999) (0)
World health organization global conference on severe acute respiratory syndrome (2004) (0)
Erratum: Update in infectious diseases (Annals of Internal Medicine (2006) 144, (49-56)) (2006) (0)
Selected topics from the 38th annual meeting of the Infectious Diseases Society of America, September 7-10, 2000, New Orleans, Louisiana and selected topics from the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, September 17-20, 2000, Toronto, Ontario, Canada. (2001) (0)
119 The Anti-HIV Drug Pipeline (2014) (0)
Introduction (2010) (0)
Origins of community strains of methicillin-resistant staphylococcus aureus (2004) (0)
Antiretroviral rounds. When success is a pain. (2001) (0)
INTENSIVE CARE UNIT ISSUES Intensive care (2017) (0)
Short-Term Growth Hormone Administration at the Time of Opportunistic Infections in HIV-Positive Patients (1999) (0)
163 The State of the ART in HIV Therapeutics (2009) (0)
Duration of antiviral immunity after smallpox vaccination (2004) (0)
Army Will Not Force Compliance with Anthrax Vaccinations (1999) (0)
Screening for HIV. (2005) (0)
Other HIV-related Pneumonias (2008) (0)
Preventing New and Recurrent CDAD (2008) (0)
Principles of clinical pharmacology in postexposure prophylaxis. Discussion (1997) (0)
Antiretroviral Therapy (2019) (0)
Product information. (1999) (0)
Random Gleanings from IDSA ʼ99 (2000) (0)
Aspiration pneumonia. (1980) (0)
Cefepime versus imipenem-cilastatin for treatment of nosocomial pneumonia in intensive care unit patients: A multicenter, evaluator-blind, prospective, randomized study (2004) (0)
IDCP Under New Editorship (2000) (0)
Severe acute respiratory syndrome and influenza: Virus incursions from Southern China (2004) (0)
Prevention of Opportunistic Infection in HIV-Infected Patients: Prophylactic Antimicrobial Agents (1995) (0)
InVitro Activity ofPenicillins Against Anaerobes (1975) (0)
OPTIMIZING HIV DRUG THERAPY (2002) (0)
I-101 Public health approach to HIV stagnation (2017) (0)
Attempting to avoid antibiotic resistance: lessons for the primary care physician. Introduction. (1999) (0)
Long-Term Central Venous Catheter Infection in HlV-Infected and Cancer Patients (1999) (0)
Penicillin-resistant Streptococcus pneumoniae-does it matter? (1997) (0)
Therapy of Clostridium difficile colitis (1981) (0)
Drug Information (2019) (0)
New Management, Consistent Focus (2005) (0)
Whole-body positron emission tomography in patients with HIV-1 infection (2004) (0)
The severe acute respiratory syndrome (2004) (0)
Herpes virus infections, HIV, and disease progression. Guarded optimism. (1995) (0)
Immune deficiency attributed to immune activation of CD8 cells with eventual replicative senescence immune activation and CD8(+) T-cell differentiation toward senescence in HIV-1 infection (2004) (0)
Comparative analysis of azithromycin and ciprofloxacin in the treatment of chronic prostatitis caused by chlamydia trachomatis (2004) (0)
Occupational risk of blood-borne viral pathogens (1993) (0)
The Ethics of Personal Stockpiles (2006) (0)
Hospitalization Due to Infectious Diseases Is Up, Relatively (1999) (0)
Selected Topics from the Seventh Conference on Retroviruses and Opportunistic Infections, January 30 - February 2, 2000 (2000) (0)
Optimizing clinical care in patients with HIV (2003) (0)
HIV Drug Resistance (2004) (0)
Emerging pathogens: Is mycobacterium avium subspecies paratuberculosis zoonotic? (2004) (0)
HIV management in challenging populations: Introduction (2006) (0)
Therapeutic challenges and enhanced clinical expectations in the treatment of HIV (2003) (0)
105 New Antivirals and New Antiviral Strategies for HIV (2012) (0)
Community-Acquired Pneumonia and Bronchitis (2003) (0)

This paper list is powered by the following services:

Other Resources About John G. Bartlett

en.wikipedia.org

What Schools Are Affiliated With John G. Bartlett?

John G. Bartlett is affiliated with the following schools: